Partnering with International Physicians
The Most Advanced, Most Compassionate Care
Nicklaus Children's Hospital works closely with international physicians to provide coordinated care to their patients. We currently receive patients from more than 80 countries worldwide. Our team stays in close contact with referring physicians before, during and after a hospital stay. Please provide detailed clinical information and complete the online International Patient Registration Form so we may expedite your request.
If you are a physician and would like to refer a patient, please contact Andrea Maggioni, MD, MBA, Director of Global Health.
Nicklaus Children's Hospital is an international leader in medical education at all levels with a strong commitment to lifelong learning, personal and professional development, and professional and scholarly work. Our Medical Education Department offers a wide array of resources for international physicians, other healthcare providers, and medical researchers.
Our multifaceted CME (Continuing Medical Education) program includes the annual Pediatric Postgraduate Course (PPGC): “Perspectives in Pediatrics”, which has attracted a distinguished international audience for almost 50 years. Nicklaus Children's is also committed to serving as a teaching hospital with highly regarded pediatric fellowship and residency training programs.
Miami Children's Research Institute is home to over 150 Investigators across nearly 30 subspecialties, and supports a wide range of clinical research studies and partnerships both locally and internationally. Our investigators are experienced in multi-site clinical investigations sponsored primarily by the pharmaceutical and medical device industries. Many investigators head research teams as principal investigators and lead sponsor-investigator studies and joint projects with academia. Nicklaus Children's Hospital investigators are knowledgeable and experienced in Phase I-IV clinical investigations in support of New Drug Applications (NDAs) and under Investigational Device Exemptions (IDEs). Their work also includes deployment of Humanitarian Use Devices (HUDs) and studies in support of orphan drug development.